Global Cardiac Markers Market 2015-2019
About cardiac markers
Cardiac markers are used for risk stratification and diagnosis of patients with suspected acute coronary syndrome and chest pain. Cardiac marker imaging is an effective, less expensive, and simple technique that helps a physician to decide whether the patient needs an invasive or complicated procedure. The cardiac marker testing is widely used in many medical settings especially for patients at low risk for cardiac death and patients with arteriosclerosis, conjunctive heart failure, sudden cardiac arrest, and myocardial infraction. The various types of cardiac markers are:
Technavio Announces the Publication of its Research Report – Global Cardiac Markers Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Cardiac Markers Market: Abbott, Alere, Roche Diagnostics and Siemens Healthcare
Other Prominent Vendors in the market are: AniBiotech, Axis-Shield, Beckman Coulter, Becton, Dickinson and Company, BG Medicine, Biomerieux, Boston Scientific, Critical Diagnostics, diaDexus, LifeSign, Mitsubishi Chemical Europe, Nanomix, Radiometer Medical, Randox Laboratories, Response Biomedical, Sierra Resources International, Singulex, Thermo Fisher Scientific and Trinity Biotech
Commenting on the report, an analyst from Technavio’s team said: “POC diagnostic tests provide immediate results, which lead to instant treatment decisions. These tests are the preferred tools for diagnosis and are gaining popularity in patient treatment evaluation. Currently, the tests that are based on lateral flow immunoassays are also available for haemoglobin testing, pregnancy testing, food pathogen screening, faecal occult blood analysis, myocardial infraction, cholesterol testing, infectious disease testing, and blood glucose testing. POC tests act as a catalyst for the development of preventive medicine because of rapid tests results and a high level of accuracy.”
According to the report, hospitals and other healthcare centers are required to reduce healthcare spending without compromising the quality of treatment and by improving patient outcomes. This can be done with the early diagnosis of cardiac disorders, which allows physicians to take care of patients during the early stages, avoiding the need for hospital stays. Cardiac markers offer reliable and efficient disease diagnosis because of high-sensitivity test kits, short turnaround time, high productivity, and easy operation of instruments. This helps in maintaining quality and reducing the costs of healthcare services.
Further, the report states lack of specific actions for detection of cardiac disorders is affecting the market growth.
Abbott, Alere, Roche Diagnostics, Siemens Healthcare, AniBiotech, Axis-Shield, Beckman Coulter, Becton, Dickinson and Company, BG Medicine, Biomerieux, Boston Scientific, Critical Diagnostics, diaDexus, LifeSign, Mitsubishi Chemical Europe, Nanomix, Radiometer Medical, Randox Laboratories, Response Biomedical, Sierra Resources International, Singulex, Thermo Fisher Scientific, Trinity Biotech
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook